Evaluating joint-space narrowing and cartilage loss in rheumatoid arthritis by using MRI

por Peterfy, Charles G, DiCarlo, Julie C, Olech, Ewa, Bagnard, Maire-Agnes, Gabriele, Annarita, Gaylis, Norman
Publicado 2012

AC-CUTE: An Open-Label Study to Evaluate Progression of Structural Joint Damage and Inflammation in Subjects with Moderate to Severe Rheumatoid Arthritis

por Bird, Paul, Peterfy, Charles, Countryman, Peter, Griffiths, Hedley, Barrett, Rina, Youssef, Peter, Joshua, Fredrick, Hall, Stephen
Publicado 2018

Monitoring cartilage loss in the hands and wrists in rheumatoid arthritis with magnetic resonance imaging in a multi-center clinical trial: IMPRESS (NCT00425932)

por Peterfy, Charles G, Olech, Ewa, DiCarlo, Julie C, Merrill, Joan T, Countryman, Peter J, Gaylis, Norman B
Publicado 2013

Pre-Treatment Whole Blood Gene Expression Is Associated with 14-Week Response Assessed by Dynamic Contrast Enhanced Magnetic Resonance Imaging in Infliximab-Treated Rheumatoid Arth...

por MacIsaac, Kenzie D., Baumgartner, Richard, Kang, Jia, Loboda, Andrey, Peterfy, Charles, DiCarlo, Julie, Riek, Jonathan, Beals, Chan
Publicado 2014

The effects of tocilizumab on osteitis, synovitis and erosion progression in rheumatoid arthritis: results from the ACT-RAY MRI substudy

por Conaghan, Philip G, Peterfy, Charles, Olech, Ewa, Kaine, Jeffrey, Ridley, David, DiCarlo, Julie, Friedman, Josh, Devenport, Jenny, Troum, Orrin
Publicado 2014

Continued inhibition of structural damage over 2 years in patients with rheumatoid arthritis treated with rituximab in combination with methotrexate

por Cohen, Stanley B, Keystone, Edward, Genovese, Mark C, Emery, Paul, Peterfy, Charles, Tak, Paul Peter, Cravets, Matt, Shaw, Tim, Hagerty, David
Publicado 2010

Safety and effectiveness of upadacitinib or adalimumab plus methotrexate in patients with rheumatoid arthritis over 48 weeks with switch to alternate therapy in patients with insuf...

por Fleischmann, Roy M, Genovese, Mark C, Enejosa, Jeffrey V, Mysler, Eduardo, Bessette, Louis, Peterfy, Charles, Durez, Patrick, Ostor, Andrew, Li, Yihan, Song, In-Ho
Publicado 2019

Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: results through 3 years from the SELECT-COMPARE study

por Fleischmann, Roy, Mysler, Eduardo, Bessette, Louis, Peterfy, Charles G, Durez, Patrick, Tanaka, Yoshiya, Swierkot, Jerzy, Khan, Nasser, Bu, Xianwei, Li, Yihan, Song, In-Ho
Publicado 2022

Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE

por Tak, Paul P, Rigby, William, Rubbert-Roth, Andrea, Peterfy, Charles, van Vollenhoven, Ronald F, Stohl, William, Healy, Emma, Hessey, Eva, Reynard, Mark, Shaw, Tim
Publicado 2011

Safety and Efficacy of Repeat Administration of Triamcinolone Acetonide Extended-release in Osteoarthritis of the Knee: A Phase 3b, Open-label Study

por Spitzer, Andrew I., Richmond, John C., Kraus, Virginia B., Gomoll, Andreas, Jones, Deryk G., Huffman, Kim M., Peterfy, Charles, Cinar, Amy, Lufkin, Joelle, Kelley, Scott D.
Publicado 2019

Inhibition of structural joint damage progression with upadacitinib in rheumatoid arthritis: 1-year outcomes from the SELECT phase 3 program

por Peterfy, Charles G, Strand, Vibeke, Friedman, Alan, Hall, Stephen, Mysler, Eduardo, Durez, Patrick, Baraliakos, Xenofon, Enejosa, Jeffrey V, Shaw, Tim, Li, Yihan, Chen, Su, Song, In-Ho
Publicado 2021

A randomized, placebo-controlled experimental medicine study of RIPK1 inhibitor GSK2982772 in patients with moderate to severe rheumatoid arthritis

por Weisel, Kathleen, Berger, Scott, Thorn, Katie, Taylor, Peter C., Peterfy, Charles, Siddall, Hilary, Tompson, Debra, Wang, Susanne, Quattrocchi, Emilia, Burriss, Susan W., Walter, Jochen, Tak, Paul Peter
Publicado 2021

Long-term safety, efficacy and inhibition of radiographic progression with abatacept treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate: 3-y...

por Kremer, Joel M, Russell, Anthony S, Emery, Paul, Abud-Mendoza, Carlos, Szechinski, Jacek, Westhovens, Rene, Li, Tracy, Zhou, Xianhuang, Becker, Jean-Claude, Aranda, Richard, Peterfy, Charles, Genant, Harry K
Publicado 2011

MRI assessment of suppression of structural damage in patients with rheumatoid arthritis receiving rituximab: results from the randomised, placebo-controlled, double-blind RA-SCORE...

por Peterfy, Charles, Emery, Paul, Tak, Paul P, Østergaard, Mikkel, DiCarlo, Julie, Otsa, Kati, Navarro Sarabia, Federico, Pavelka, Karel, Bagnard, Marie-Agnes, Gylvin, Lykke Hinsch, Bernasconi, Corrado, Gabriele, Annarita
Publicado 2016

Magnetic resonance imaging of the hand and wrist in a randomized, double-blind, multicenter, placebo-controlled trial of infliximab for rheumatoid arthritis: Comparison of dynamic...

por Beals, Chan, Baumgartner, Richard, Peterfy, Charles, Balanescu, Andra, Mirea, Gavrila, Harabagiu, Alexandru, Popa, Serghei, Cheng, Amy, Feng, Dai, Ashton, Edward, DiCarlo, Julie, Vallee, Marie-Helene, Dardzinski, Bernard J.
Publicado 2017

Sustained improvements in MRI outcomes with abatacept following the withdrawal of all treatments in patients with early, progressive rheumatoid arthritis

por Peterfy, Charles, Burmester, Gerd R, Bykerk, Vivian P, Combe, Bernard G, DiCarlo, Julie C, Furst, Daniel E, Huizinga, Tom W J, Wong, Dennis A, Conaghan, Philip G, Emery, Paul
Publicado 2016

Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheumatoid arthritis and an inadequate response to methotrexate: the ASSET randomised...

por Conaghan, Philip G, Durez, Patrick, Alten, Rieke E, Burmester, Gerd-Rüdiger, Tak, Paul P, Klareskog, Lars, Catrina, Anca Irinel, DiCarlo, Julie, Gaillez, Corine, Le Bars, Manuela, Zhou, Xianhuang, Peterfy, Charles
Publicado 2013

Atlas for the OMERACT thumb base osteoarthritis MRI scoring system (TOMS)

por Kroon, Féline P B, Peterfy, Charles G, Conaghan, Philip G, Foltz, Violaine, Gandjbakhch, Frédérique, Eshed, Iris, Genant, Harry K, Østergaard, Mikkel, Reijnierse, Monique, Bloem, Johan L, Haugen, Ida K, Kloppenburg, Margreet
Publicado 2018

Maintenance of remission following 2 years of standard treatment then dose reduction with abatacept in patients with early rheumatoid arthritis and poor prognosis

por Westhovens, Rene, Robles, Manuel, Ximenes, Antonio Carlos, Wollenhaupt, Jurgen, Durez, Patrick, Gomez-Reino, Juan, Grassi, Walter, Haraoui, Boulos, Shergy, William, Park, Sung-Hwan, Genant, Harry, Peterfy, Charles, Becker, Jean-Claude, Murthy, Bindu
Publicado 2015

Repeatability and response to therapy of dynamic contrast-enhanced magnetic resonance imaging biomarkers in rheumatoid arthritis in a large multicentre trial setting

por Waterton, John C., Ho, Meilien, Nordenmark, Lars H., Jenkins, Martin, DiCarlo, Julie, Guillard, Gwenael, Roberts, Caleb, Buonaccorsi, Giovanni, Parker, Geoffrey J. M., Bowes, Michael A., Peterfy, Charles, Kellner, Herbert, Taylor, Peter C.
Publicado 2017